About 6th Annual European Life Sciences CEO Forum
The 6th Annual European Life Sciences CEO Forum, is being held on 5th-6th March 2013 at the Hilton Zurich Airport Hotel, Switzerland. This event will be highly transactional, bringing together an exciting cross-section of venture-funded and small-cap companies with leading investors, pharmas, and scientific thought leaders. We expect around 350 delegates and 80 presenting companies. Information about the last year’s event is available on the event’s website here.
The programme will comprise of Plenary panels with confirmed chairs including:
MAIN PANELS TO COVER:
Public Markets and M&A chaired by:
Stephanie Leouzon, Senior Advisor, Torreya Partners
Investment chaired by:
Regina Hodits, General Partner, Wellington Partners
Thomas Stockman, Director Healtcare Investment Banking, Citi Group
Partnering chaired by:
Fintan Walton, CEO and Founder, PharmaVentures
SPECIALIST PANELS INCLUDE:
MedTech & Device chaired by:
Markus Hosang, General Partner, BioMedPartners AG
Neuroscience chaired by:
Lubor Gaal, Head of Europe, Strategic Transactions Group, BMS
Saira Ramasastry, Managing Partner, Life Science Advisory, LLC
Oncology & Diagnostics chaired by:
Christina Takke, Partner, Forbion Captial Partners
Chris Britten, Independent Consultant
Platform Technologies & Novel Therapeutics chaired by:
Esteban Pombo Villar, Chief Operations Officer, Oxford BioTherapeutics
Katya Smirnyagina, Venture Partner, Capricorn Venture Partners
Regenerative Medicine chaired by:
Lorenza Castellon, Health and Biotech Equity Analyst, Equity Development
Vaccines chaired by:
Florian Schodel, CEO, Philimmune LLC
NEW FOR 2013
Israel Panel chaired by:
Laurent Choppe, Managing Partner, Life Sciences, Cukierman and Co.
Einat Zisman, CEO, Hadasit Medical Research Services & Development Ltd.
Daniel Teper, CEO, Immune Pharma
Ora Dar, Head of the Life Sciences, Office of the Chief Scientist,
Ministry of Industry, Trade and Labor, Israel
Tomer Kariv, Co-Founder and CEO, Pontifax Corp.
Venture Investment Panel chaired by:
Alexey Eliseev, Managing Director, Maxwell Biotech Venture Fund
Chris Janssen, Director of Science and Innovation, Biomedical Cluster,
Olga Potapova, CEO, Cureline
Igor Pivovarov, CEO, HemaCore
Others - TBA
Pharma Partners and Investment Opportunities Panel chaired by:
Irena Melnikova, Managing Director Russia, Burrill & Company
Julia Sardaryan, Head of Business Development, OCT Clinical Trials
Rustam Ixanov, Vice-President of Strategic Development,
AKRIKHIN Pharmaceuticals Co.
Vasily Ignatiev, CEO, R-Pharm
Others - TBA
Emerging Companies Panel chaired by:
Peter Burckhardt, CEO, EVA – the Basel life sciences start-up agency
Søren Møller, Managing Investment Director, Novo Seeds
...and more to be announced later
See our Confirmed Speakers and Chairs >>>
Presenting at the forum offers excellent opportunities to showcase your company to some of the leading global investors and corporates. It will offer you the opportunity to communicate your projected capital raising plans or simply help you in finding the right partner for your business.
Presenting companies from Europe and the US will benefit from specially designed panels and keynote addresses from leading industry figures as well as access to some of the leading analysts and investors from Europe and beyond. This year, we aim to expand the audience and provide once again, opportunities for executive-level networking, deal-making and strategic partnering.
The forum is recognised as the leading international stage for those interested in investing in the biotech and life science industry and is highly transactional, drawing together an exciting cross-section of early-stage/pre-IPO, late-stage and public companies with leading investors, analysts, money managers and pharmas. Supported and designed by leading figures within Europe’s bio industry, this event will once again be covered by our regular media partners.
Sachs Associates has developed an extensive knowledge
of the key individuals operating within the European and global biotech
industry. This together with a growing reputation for excellence puts
Sachs Associates at the forefront of the industry and provides a powerful
tool by which to increase the position of your company in this market.
Raise your company’s profile directly with
your potential clients. All of our sponsorship packages are tailor made
to each client, allowing your organisation to gain the most out of attending
our industry driven events.
To learn more about
Zoe Harris +
44 (0)203 463 4890 or
by email: Zoe Harris.